Quit Genius - Alcohol for Alcoholism

Phase-Based Progress Estimates
Quit Genius, New York, NYAlcoholismMobile health application - Other
All Sexes
What conditions do you have?

Study Summary

This trial will compare two methods of treating alcohol use disorder to determine which is more effective and cost-effective.

Eligible Conditions
  • Alcoholism

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline to 6-months post-treatment entry

Baseline to 6-months post-treatment entry
Alcohol use

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Medical Management
1 of 2
Quit Genius - Alcohol
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Quit Genius - Alcohol · No Placebo Group · Phase 3

Quit Genius - Alcohol
Experimental Group · 1 Intervention: Mobile health application · Intervention Types: Other
Medical Management
ActiveComparator Group · 1 Intervention: Medical Management · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 6-months post-treatment entry

Who is running the clinical trial?

Quit GeniusLead Sponsor

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must live in the United States.
You have an iPhone (5th generation or newer) or an Android phone (version 18 or newer).
You have been diagnosed with a moderate or severe Alcohol Use Disorder according to the Diagnostic and Statistical Manual-V.
You are willing to take the medication called naltrexone.

Frequently Asked Questions

Are additional participants being sought for this clinical trial?

"Per the data posted on clinicaltrials.gov, this project is actively accepting participants at present. It was initially published on January 1st 2023 and underwent its most recent update on February 17th of that same year." - Anonymous Online Contributor

Unverified Answer

How many individuals are involved in this research endeavor?

"Affirmative. Clinicaltrials.gov confirms that this medical trial, which was initially published on January 1st 2023, is currently accepting participants. Roughly 300 individuals must be enlisted from a single site." - Anonymous Online Contributor

Unverified Answer

Has Quit Genius - Alcohol attained FDA authorization?

"Our team at Power assigned Quit Genius - Alcohol a rating of 3, due to the abundant evidence underpinning its efficacy and safety from Phase 3 clinical trials." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.